②The levels of fast blood glucose(FBG) and triglycerides(TG) in IGT group were significantly higher than those in controls,while the level of high-density lipoprotein cholesterol(HDL-C) was greatly decreased(P<0.05 or 0.01).
Meanwhile,such indexes as TG,TC,LDL,BP,BML and WHR have remarkably been reduced,while the level of HDL has been increased in the group of aerobic exercises.
Plasma adiponectin and high-density lipoproteins (HDL-C) significantly elevated in pioglitazone group comparing with those before treatment and placebo group (P<0.05 or P<0.01).
One-way ANOVA revealed differences in the erythrocyte suspension viscosity, total globulins, triglycerides, high density lipoprotein cholesterol (HDL Ch), plasma viscosity, and acid resistance of erythrocytes.
The statistically significant two-way interaction effects of ADH7 StyI and CYP2E1 DraI on diastolic blood pressure (P = 0.029) and on the serum high density lipoprotein level (P = 0.042) were also revealed.
Plasma triglyceride (TG), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C) and apoA-I concentrations were markedly increased in T0901317-treated groups.
Body mass index (BMI) and lipid profile including total cholesterol, low density lipoprotein cholesterol, high density lipoprotein cholesterol and triglyceride correlated with blood pressure.
In pcDNA3.1-Retn-treated mice, both free fatty acid (FFA) and high density lipoprotein (HDL) cholesterol levels were markedly lower than those of control, whereas HDL cholesterol and triglyceride (TG) levels did not differ between the two groups.
Mean serum high-density lipoprotein cholesterol (HDL-c) levels were decreased significantly from 1982-1983 to 1997-1999, with the changes from -13.2% to -38.6% in males and from -9.8% to -21.7% in females.
The ratio of total cholesterol to high-density lipoprotein cholesterol (TC/HDL-c) increased dramatically during this period because of a concurrent decline in the levels of HDL-c and the increase in the levels of TC.
We evaluated the efficacy of alternate-day dosing of atorvastatin in comparison with the standard one-daily dose on total cholesterol, low and High-density lipoprotein (LDL and HDL) and triglycerides.
CETP thus plays a potential pro-atherogenic role by moving CE from HDL into pro-atherogenic VLDL and LDL particles, thereby lowering atheroprotective HDL cholesterol.
Mean serum high-density lipoprotein cholesterol (HDL-c) levels were decreased significantly from 1982-1983 to 1997-1999, with the changes from -13.2% to -38.6% in males and from -9.8% to -21.7% in females.
The ratio of total cholesterol to high-density lipoprotein cholesterol (TC/HDL-c) increased dramatically during this period because of a concurrent decline in the levels of HDL-c and the increase in the levels of TC.
In pcDNA3.1-Retn-treated mice, both free fatty acid (FFA) and high density lipoprotein (HDL) cholesterol levels were markedly lower than those of control, whereas HDL cholesterol and triglyceride (TG) levels did not differ between the two groups.
High density lipoprotein (HDL) plays a central role in the removal of excess cholesterol from cells, and cholesteryl ester transfer protein (CETP) is a crucial protein involved in the regulation of HDL levels.
Effect of antiatherogenic high density lipoprotein (HDL) and apolipoprotein AI (apoAI) on production of prostaglandin E2(PGE2) by human monocyte-derived macrophages was investigated.
The liver is also the major site of uptake of3H-CLE-high density lipoprotein (HDL) (40%-45% of the injected dose) but its uptake by the liver increased only by 20% with estradiol treatment.
The thiazides hydrochlorothiazide and chlorthalidone cause an elevation of plasma triglycerides and very low density lipoprotein (VLDL) but have little effect on total cholesterol, low density lipoprotein (LDL) and high density lipoprotein (HDL).